Multi-target simultaneous detection method based on proximity ligation assay

By combining microbead enrichment with a clip probe, the problem of low target conjugation efficiency in solid-phase PLA detection is solved, achieving high sensitivity and specificity detection of multiple targets, which is suitable for biomedical research, early disease diagnosis, and drug screening.

WO2026233474A1PCT designated stage Publication Date: 2026-11-12HANGZHOU INNOVATION RES INST OF BEIJING UNIV OF AERONAUTICS & ASTRONAUTICS +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
PCT/CN2026/106267
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-05-09
Filing Date
2026-06-25
Publication Date
2026-11-12

AI Technical Summary

Technical Problem

In solid-phase PLA detection, probe-dependent random collisions lead to low-abundance target connectivity efficiency, making it difficult to achieve high sensitivity and specificity for multiplex detection.

Method used

By combining microbead enrichment technology with clip probes, target molecules are enriched by coating the surface of microbeads with antibodies, and clip probes are used to replace conventional linkers to achieve simultaneous detection of multiple targets.

Benefits of technology

It significantly improves the detection sensitivity of low-abundance target molecules, enabling the detection of target molecules as low as 0.001 ng/mL, and provides accurate multi-target detection results, reducing the problem of low detection rates caused by adjacent probes crossing and approaching each other.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN2026106267_12112026_PF_FP_ABST
    Figure CN2026106267_12112026_PF_FP_ABST
Patent Text Reader

Abstract

The present application relates to a multi-target simultaneous detection method based on proximity ligation assay (PLA). The present application provides a method for simultaneously detecting multiple targets by using PLA based on microbead-based enrichment. The method comprises: using a plurality of microbeads coated with antibodies that recognize different targets to simultaneously enrich a plurality of target molecules, and binding the target molecules to proximity probes; then using a splint probe to ligate the proximity probes; and finally, detecting the multiple different target molecules by means of qPCR detection. The method of the present application can not only simultaneously detect multiple different target molecules, but also achieve higher detection accuracy compared with conventional methods.
Need to check novelty before this filing date? Find Prior Art

Description

A method for simultaneous detection of multiple targets based on adjacency connectivity

[0001] Cross-references to related applications

[0002] This application claims priority to Chinese Patent Application No. 202510595605.8, filed on May 9, 2025, the entire contents of which are incorporated herein by reference. Technical Field

[0003] This application belongs to the field of biological detection technology, specifically relating to a method for simultaneous detection of multiple targets based on adjacent linkages. Background Technology

[0004] Proximity Ligation Assay (PLA) is a highly sensitive in vitro protein analysis technique based on enzyme-linked molecules and linkers (artificially designed linear oligonucleotide single-stranded molecules whose ends are complementary to specific target sequences. When the linker hybridizes with the target sequence, they move spatially close to each other, and the two ends of the probes can be joined together by DNA ligase). This method first uses a pair of adjacent probes to perform dual recognition of the target molecule, generating an amplifiable detection signal. Then, quantitative PCR is used to achieve timed and quantitative detection, transforming protein detection into DNA detection, exhibiting extremely high sensitivity and specificity. PLA can analyze low-abundance proteins by amplifying the signal of antibody-antigen binding events, making it suitable for developing multiplex detection techniques capable of simultaneously quantifying protein and nucleic acid targets.

[0005] PLA detection includes various forms, such as homogeneous assays and solid-phase assays. Among them, solid-phase PLA detection is favored because it can enrich target molecules with low abundance and eliminate the influence of other substances in complex biological samples on the determination. However, solid-phase PLA detection still suffers from the problem of probe-dependent random collisions, making it difficult to effectively bind to low-abundance targets, resulting in low PLA detection efficiency.

[0006] In fields such as biomedical research, early disease diagnosis, drug screening, and environmental monitoring, the sensitivity, specificity, and multiplex detection of target molecules have always been core issues in analytical science. Especially in clinical diagnosis, the occurrence and development of many diseases are often accompanied by the abnormal expression of multiple biomarkers. Therefore, developing a method capable of simultaneous, accurate, and quantitative detection of multiple targets is of great significance for early disease screening, subtyping diagnosis, and personalized treatment. Summary of the Invention

[0007] To address the aforementioned issues, this application provides a method for simultaneous detection of multiple targets based on PLA enrichment assay using microbeads. Specifically, target molecules are enriched by coating microbeads with antibodies. Since each microbead can load up to hundreds of antibodies, multiple target molecules can be enriched on a single microbead, resulting in a significantly higher enrichment level. This facilitates subsequent probe ligation and significantly improves ligation efficiency. Furthermore, this application uses multiple microbeads coated with antibodies recognizing different targets to simultaneously enrich multiple target molecules, achieving simultaneous detection of multiple targets. In addition, this application also addresses the signal loss problem encountered when using conventionally designed linkers in this process, which is overcome by using the clip-on probe designed in this application.

[0008] Specifically, this application provides a method for simultaneous detection of multiple targets based on adjacency connectivity, which includes the following steps:

[0009] (a) Providing a plurality of microbead complexes, each of the plurality of microbead complexes comprising:

[0010] (i) Microbead carriers; and

[0011] (ii) A first antibody that specifically binds to the target molecule immobilized on the surface of the microbead carrier;

[0012] The primary antibodies immobilized on different microbead complexes each specifically bind to different target molecules;

[0013] (b) The various microbead complexes are incubated with the test sample so that the first antibody immobilized on the different microbead complexes binds to its respective target molecule;

[0014] (c) Separate the various microbead complexes from the sample to be tested to obtain various microbead complexes that bind different target molecules;

[0015] (d) Incubate multiple microbead complexes bound to different target molecules with multiple first adjacent probes and second adjacent probe pairs, wherein the multiple first adjacent probes and second adjacent probe pairs correspond to different target molecules, wherein the first adjacent probe contains a second antibody coupled to the 5' end of a first oligonucleotide, and the second adjacent probe contains a third antibody coupled to the 3' end of a second oligonucleotide. The sequences of the first and second oligonucleotides in each pair of first adjacent probes and second adjacent probes are different among the multiple first adjacent probes and second adjacent probe pairs, but all first oligonucleotides have the same first adaptor sequence at the 3' end and all second oligonucleotides have the same second adaptor sequence at the 5' end. Furthermore, the second and third antibodies in each pair of first adjacent probes and second adjacent probes bind to different epitopes on the target molecules corresponding to the first adjacent probe and second adjacent probe pair, thereby obtaining multiple microbead complexes bound to multiple first adjacent probes and second adjacent probe pairs.

[0016] (e) The multi-bead complex from step (d) is incubated with a clip probe, the clip probe consisting of short hairpins at both ends and a hybridization region in the middle, the hybridization region containing complementary sequences complementary to the first and second adaptor sequences respectively, such that the 3' end of the first oligonucleotide and the 5' end of the second oligonucleotide become adjacent to each other through hybridization with the clip probe.

[0017] (f) Incubate the multi-bead complex from step (e) with DNA ligase so that the 3' end of the adjacent first oligonucleotide is linked to the 5' end of the second oligonucleotide.

[0018] (g) The multiple microbead complexes from step (f) are mixed with a qPCR reaction system containing multiple primer pairs and a qPCR reaction is performed to determine the presence of a target molecule or two interacting target molecules, wherein the multiple primer pairs correspond to multiple first adjacent probes and second adjacent probe pairs, and each primer pair consists of an upstream primer and a downstream primer that are complementary to the first oligonucleotide and the second oligonucleotide in the corresponding first adjacent probe and second adjacent probe pair.

[0019] As used in this application, a plurality of microbead complexes may include at least two microbead complexes that specifically recognize different target molecules, such as at least 3, 4, 5, 6, 7, 8, 9, 10, 20, 30, 40, 50, 60, 70, 80, 90, 100 or more microbead complexes. Each microbead complex has a first antibody that specifically binds to the same target molecule immobilized on its microbeads; that is, each microbead complex specifically recognizes the same target molecule. Furthermore, each microbead complex may contain at least one or more microbead complexes that specifically recognize the same target molecule, such as at least 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 20, 30, 40, 50, 60, 70, 80, 90, 100 or more microbead complexes.

[0020] Furthermore, the microbead carrier is a magnetic bead with surface carboxylation, amylation, or streptavidin modification.

[0021] Furthermore, the first antibody is immobilized on the surface of the microbeads by chemical cross-linking or biotin-streptavidin binding.

[0022] Furthermore, the conjugation of the second and third antibodies to oligonucleotides is achieved through chemical cross-linking or biotin-streptavidin binding.

[0023] Furthermore, the chemical crosslinking is selected from EDC / NHS coupling, click chemistry (CuAAC), or maleimide-thiol reaction.

[0024] Specifically, CuAAC is a copper-catalyzed azido-alkyne cycloaddition reaction, belonging to one of the most classic and widely used reactions in click chemistry. Its reaction principle is as follows: Two groups are pre-modified on the antibody / oligonucleotide: one modified with an azide group, and the other modified with a terminal alkyne group; then, a monovalent copper ion (Cu...) is added... + Under catalysis, azide and alkyne undergo specific cyclization to stably generate a triazole five-membered ring, covalently linking the two molecules.

[0025] Furthermore, the antibody may be a monoclonal antibody or a polyclonal antibody.

[0026] As used in this application, the first antibody in each microbead complex and the second and third antibodies in each corresponding first or second or second adjacent probe pair can specifically bind to the same target molecule, but each recognizes a different epitope on the target molecule, i.e., they have different antigenic determinants.

[0027] Furthermore, the clip probe is a dumbbell-shaped oligonucleotide, comprising short hairpins at both ends and a hybridization region in the middle.

[0028] Furthermore, each of the short hairpins at both ends of the clamp probe has a ring of 4-6 bases in length and an inverse complementary double strand of 4-6 base pairs in length.

[0029] Furthermore, the hybridization region in the middle of the clamp probe is a single strand with a length of 8-12 bases, wherein the length of the complementary sequence complementary to the first adaptor sequence is 4-6 bases, and the length of the complementary sequence complementary to the second adaptor sequence is 4-6 bases.

[0030] Preferably, the short hairpins at both ends of the clip probe each have a loop of 4 bases in length and an inverse complementary double strand of 4 base pairs in length, and the complementary sequence complementary to the first linker sequence is 6 bases in length, and the complementary sequence complementary to the second linker sequence is 6 bases in length.

[0031] Furthermore, the method may combine steps e to form a single step. For example, it may include incubating the multiple microbead complexes from step (d) with a qPCR reaction system containing a splint probe, DNA ligase, and multiple primer pairs and performing a qPCR reaction to determine the presence of multiple target molecules.

[0032] Furthermore, the DNA ligase is a T4 DNA ligase.

[0033] Furthermore, the qPCR reaction system also includes reaction buffer, Taq DNA polymerase, ATP, dNTPs, various detection probes, and nuclease-free water.

[0034] Furthermore, each of the multiple detection probes is used to detect different target molecules, for example, it is complementary to the first or second oligonucleotide in multiple first adjacent probe and second adjacent probe pairs corresponding to different target molecules.

[0035] Furthermore, each of the various detection probes is labeled with a fluorescent group and a quenching group at both ends, and the fluorescent groups of the various detection probes are different from each other.

[0036] Furthermore, the fluorescent group may be selected from, but is not limited to, FAM, HEX, VIC, TET, ROX, CY5, etc.; the quenching group may include at least one of TAMRA, MGB, BHQ1, BHQ2 and BHQ3.

[0037] Furthermore, the detection probe is a Taqman probe.

[0038] The beneficial effects of this application are:

[0039] This application first improves upon existing solid-phase PLA assays by utilizing microbeads coated with a large amount of antibody to highly enrich target molecules, enabling more efficient collision and binding between adjacent probes and target molecules. As demonstrated in the examples, the method of this application can detect target molecules as low as 0.001 ng / mL, exhibiting excellent detection sensitivity.

[0040] However, in this method, multiple neighboring probes bind to various target molecules simultaneously on the same microbead. The presence of numerous neighboring probes on the same microbead can lead to cross-proximity between neighboring probes of different target molecules, resulting in a lower detected number of target molecules than the actual number. Conventional linkers are typically quite long, reaching approximately 30 bp, due to considerations of both template binding strength and specificity, as well as the double-strand length required for ligase ligation. This application found that linkers of such length resulted in the aforementioned lower measured values ​​when performing microbead-enriched PLA assays. To address this issue, this application employs a unique clip probe to replace the conventional linker, finding that it can more accurately detect the presence of target molecules. Compared to conventional linkers, the clip probe's short hairpin structure at both ends allows for stable binding and ligation by the ligase, resulting in a shorter length. Furthermore, the dumbbell-shaped clip probe has higher rigidity and lower molecular chain flexibility, making it more suitable for the microbead-enriched PLA method of this application and reducing cross-proximity between neighboring probes of multiple target molecules.

[0041] Based on this, in order to achieve simultaneous detection of multiple targets, this application will simultaneously incubate the test sample with microbead complexes that identify different target molecules, and improve the sequence of the adjacent probe pair to introduce a universal linker sequence, so that a single clip probe can be used to achieve simultaneous detection of multiple different targets. Attached Figure Description

[0042] The above and other objects, features, and advantages of exemplary embodiments of this application will become readily apparent from the following detailed description taken in conjunction with the accompanying drawings. Several embodiments of this application are illustrated in the drawings by way of example and not limitation, in which:

[0043] In the accompanying drawings, the same or corresponding reference numerals indicate the same or corresponding parts.

[0044] Figure 1 shows a schematic diagram of the structure of the clamp probe of this application;

[0045] Figure 2 shows the amplification curves of TNF-α (three replicate experiments) of this application;

[0046] Figure 3 shows the amplification curve of IL-6 (three replicate experiments) in this application;

[0047] Figure 4 shows the linear analysis results of TNF-α (three repeated experiments) in this application;

[0048] Figure 5 shows the linear analysis results of IL-6 (three repeated experiments) in this application. Embodiments of the present invention

[0049] The present application is further illustrated below with reference to specific embodiments, but the embodiments do not limit the present application in any way. Unless otherwise specified, the reagents, methods and equipment used in this application are conventional reagents, methods and equipment in the art.

[0050] The sequences of oligonucleotides, splint probes, and primers used in the examples, as well as the conventional linkers used in the comparative examples, are shown in Table 1.

[0051] Table 1. Sequences of conventional connectors

[0052]

[0053] Example: Determination of TNF-α and IL-6 content in samples by enriching PLA with microbeads.

[0054] (1) Preparation of microbead complex mixture targeting TNF-α and IL-6: 1 μL of Dynabeads™ MyOne™ StreptavidinT1 magnetic beads were incubated with 100 μL of TNF-α or IL-6 primary antibody dilution (concentration of 100 μg / mL) at room temperature for 30 min with stirring. The magnetic beads were collected by magnetic separation, washed 3 times with 10 mM PBS, and then incubated with 10 mM PBS containing 0.1% BSA for 15 min with shaking. The magnetic beads targeting TNF-α and IL-6 were collected and mixed together and resuspended in 10 mM PBS.

[0055] (2) TNF-α and IL-6 proteins were simultaneously dissolved in 10 mM PBS to prepare mixed sample solutions of different concentrations (0 ng / mL, 0.1 ng / mL, 1 ng / mL, 10 ng / mL, 100 ng / mL, and 1000 ng / mL of TNF-α and IL-6 proteins respectively), and incubated with microbead complex at room temperature for 1 h respectively;

[0056] (3) The magnetically separated microbead complex was washed three times and then resuspended in 50 μL of 10 mM PBS;

[0057] (4) Prepare ortho-probes for TNF-α and IL-6 respectively: Take 10 μL of 2 μg / μL of the second antibody and the third antibody respectively, add 1 μL of 4 mM dibenzocyclooctyne-PEG4-N-hydroxysuccinimide ester (DBCO) and react at room temperature for 30 minutes to add an NHS group to the N end. Add 1 μL of 1 M Tris-HCl and incubate at room temperature for 5 minutes to terminate the above reaction; Incubate 20 μg of the second antibody and the third antibody modified with the NHS group with 40 μM of the first oligonucleotide with an azide group at the 5' end and the second oligonucleotide with an azide group at the 3' end dissolved in 10 mM PBS at 4°C overnight to couple the second antibody to the 5' end of the first oligonucleotide and the third antibody to the 3' end of the second oligonucleotide to obtain the first and second ortho-probes;

[0058] (5) Dilute the first and second ortho-probes targeting TNF-α and IL-6 respectively with PBS to 1 μg / mL, mix the four probe solutions in equal volumes, and then mix them in equal volumes with the microbead complex obtained in step (3). Incubate at room temperature for 90 min to obtain the incubation solution.

[0059] (6) Prepare the PCR reaction system according to Table 2.

[0060] Table 2: Components of the PCR reaction system

[0061]

[0062] (7) Add 5 μL of incubation solution to the PCR reaction system in step (6), perform qPCR reaction according to the procedure in Table 3 and output Ct value. The amplification curves of TNF-α and IL-6 (three replicate experiments) are shown in Figure 2 and Figure 3, respectively, and their linear analysis is shown in Figure 4 and Figure 5, respectively.

[0063] Table 3: qPCR reaction procedure

[0064]

[0065] Comparative example: The content of TNF-α in samples enriched in microbeads was determined using conventional linkers.

[0066] Steps (1)-(5) are the same as in the embodiment;

[0067] Step (6): Replace the clamp probes in Table 2 with connectors, leaving the rest of the components unchanged;

[0068] Step (7) is the same as in the example. The relationship between the output Ct value and concentration of TNF-α and IL-6 was detected. It was found that the linear relationship of PLA multitarget detection using microbeads enriched with conventional linkers was poor compared with the clip probe used in this application, indicating that there is interference in the detection using conventional linkers.

[0069] It should be noted that while preferred embodiments of this application are provided in the specification and accompanying drawings, this application can be implemented in many different forms and is not limited to the embodiments described herein. These embodiments are not intended to impose additional limitations on the content of this application; their purpose is to provide a more thorough and comprehensive understanding of the disclosure of this application. Furthermore, the above-described technical features can be combined with each other to form various embodiments not listed above, all of which are considered to be within the scope of this application's specification. Moreover, those skilled in the art can make improvements or modifications based on the above description, and all such improvements and modifications should fall within the protection scope of the appended claims.

Claims

1. A method for simultaneous detection of multiple targets based on adjacency connectivity, comprising the following steps: (a) Providing a plurality of microbead complexes, each of the plurality of microbead complexes comprising: (i) Microbead carriers; and (ii) A first antibody that specifically binds to the target molecule immobilized on the surface of the microbead carrier; The primary antibodies immobilized on different microbead complexes each specifically bind to different target molecules; (b) The various microbead complexes are incubated with the test sample so that the first antibody immobilized on the different microbead complexes binds to its respective target molecule; (c) Separate the various microbead complexes from the sample to be tested to obtain various microbead complexes that bind different target molecules; (d) Incubate multiple microbead complexes bound to different target molecules with multiple first adjacent probes and second adjacent probe pairs, wherein the multiple first adjacent probes and second adjacent probe pairs correspond to different target molecules, wherein the first adjacent probe contains a second antibody coupled to the 5' end of a first oligonucleotide, and the second adjacent probe contains a third antibody coupled to the 3' end of a second oligonucleotide. The sequences of the first and second oligonucleotides in each pair of first adjacent probes and second adjacent probes are different among the multiple first adjacent probes and second adjacent probe pairs, but all first oligonucleotides have the same first adaptor sequence at the 3' end and all second oligonucleotides have the same second adaptor sequence at the 5' end. Furthermore, the second and third antibodies in each pair of first adjacent probes and second adjacent probes bind to different epitopes on the target molecules corresponding to the first adjacent probe and second adjacent probe pair, thereby obtaining multiple microbead complexes bound to multiple first adjacent probes and second adjacent probe pairs. (e) The multi-bead complex from step (d) is incubated with a clip probe, the clip probe consisting of short hairpins at both ends and a hybridization region in the middle, the hybridization region containing complementary sequences complementary to the first and second adaptor sequences respectively, such that the 3' end of the first oligonucleotide and the 5' end of the second oligonucleotide become adjacent to each other through hybridization with the clip probe. (f) Incubate the multi-bead complex from step (e) with DNA ligase so that the 3' end of the adjacent first oligonucleotide is linked to the 5' end of the second oligonucleotide. (g) The multiple microbead complexes from step (f) are mixed with a qPCR reaction system containing multiple primer pairs and a qPCR reaction is performed to determine the presence of a target molecule or two interacting target molecules, wherein the multiple primer pairs correspond to multiple first adjacent probes and second adjacent probe pairs, and each primer pair consists of an upstream primer and a downstream primer that are complementary to the first oligonucleotide and the second oligonucleotide in the corresponding first adjacent probe and second adjacent probe pair.

2. The method according to claim 1, wherein the microbead carrier is a magnetic bead modified with surface carboxylation, amylation, or streptavidin.

3. The method according to claim 1, wherein the first antibody is immobilized on the surface of the microbeads by chemical cross-linking or biotin-streptavidin binding.

4. The method according to claim 1, wherein the conjugation of the second and third antibodies to the oligonucleotides is achieved by chemical cross-linking or biotin-streptavidin binding.

5. The method according to claim 4, wherein the chemical crosslinking is selected from EDC / NHS coupling, click chemistry, or maleimide-thiol reaction.

6. The method according to claim 1, wherein the short hairpins at both ends of the clip probe each have a loop of 4-6 bases in length and an inverse complementary double strand of 4-6 base pairs in length, and the complementary sequences of the hybridization region in the middle of the clip probe that are complementary to the first adapter sequence and the second adapter sequence are both 4-6 bases in length.

7. The method according to claim 1, wherein the method comprises incubating the multi-bead complex of step (d) with a qPCR reaction system comprising a splint probe, a DNA ligase and multiple primer pairs and performing a qPCR reaction to determine the presence of multiple target molecules.

8. The method according to claim 7, wherein the qPCR reaction system further comprises reaction buffer, Taq DNA polymerase, ATP, dNTPs, multiple detection probes and nuclease-free water.

9. The method according to claim 8, wherein the two ends of the plurality of detection probes are respectively labeled with a fluorescent group and a quenching group, and the fluorescent groups of the plurality of detection probes are all different from each other.